Location History:
- Frankfurt-am-Main, DE (1981 - 1984)
- Uehlfeld, DE (1984 - 1985)
- Alzenau, DE (1985 - 2000)
Company Filing History:
33 out of 260 
5 out of 539 
2 out of 2 
Years Active: 1981-2000
Areas of Expertise:
Title: Innovations and Contributions of Karl Schonafinger in Pharmaceuticals
Introduction
Karl Schonafinger, located in Alzenau, Germany, is a notable inventor in the field of pharmaceuticals, renowned for his significant contributions through 41 patents. His research and innovations focus on developing compounds aimed at treating various cardiovascular diseases, demonstrating his commitment to advancing medical science.
Latest Patents
Among Karl's most recent patents is the development of pyrazole derivatives, which are derivatives of the formula I. These compounds have proven to be useful in the therapy and prophylaxis of a wide range of illnesses, particularly cardiovascular conditions such as hypertension, angina pectoris, cardiac insufficiency, thromboses, and atherosclerosis. The invention emphasizes the compounds' ability to modulate the body's production of cyclic guanosine monophosphate (cGMP), thereby addressing health issues associated with disturbed cGMP balance. Additionally, another recent patent pertains to the use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives, which serve as pharmacologically active compounds beneficial for various medical applications.
Career Highlights
Throughout his career, Karl Schonafinger has collaborated with notable pharmaceutical companies, including Cassella Aktiengesellschaft and Hoechst Roussel Pharmaceuticals. His work has not only advanced the field of pharmacology but has also contributed to the development of innovative therapeutic options for patients.
Collaborations
Karl has worked alongside esteemed colleagues such as Helmut Bohn and Rudi Beyerle. Their collective efforts in research and development have played a pivotal role in advancing pharmaceutical inventions, reinforcing the importance of collaboration in the quest for medical breakthroughs.
Conclusion
In summary, Karl Schonafinger's dedication to innovation in the pharmaceutical industry has led to the creation of numerous patents that hold significant potential for treating life-threatening diseases. His contributions, coupled with collaborations with prominent organizations and individuals, highlight the impact of scientific research and innovation in improving health outcomes globally.